Cite
Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma
MLA
Wan-Hong Huang, et al. “Cyproheptadine, an Epigenetic Modifier, Exhibits Anti-Tumor Activity by Reversing the Epigenetic Silencing of IRF6 in Urothelial Carcinoma.” Cancer Cell International, vol. 21, Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....88d0d2a7f73807f9be70a768161b294d&authtype=sso&custid=ns315887.
APA
Wan-Hong Huang, Guan-Ling Lin, Shu-Fen Wu, Hon-Yi Lin, Yeong-Chin Jou, Cheng-Huang Shen, Yu-Ming Chuang, Ru-Inn Lin, Michael W.Y. Chan, & Pie-Che Chen. (2021). Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma. Cancer Cell International, 21.
Chicago
Wan-Hong Huang, Guan-Ling Lin, Shu-Fen Wu, Hon-Yi Lin, Yeong-Chin Jou, Cheng-Huang Shen, Yu-Ming Chuang, Ru-Inn Lin, Michael W.Y. Chan, and Pie-Che Chen. 2021. “Cyproheptadine, an Epigenetic Modifier, Exhibits Anti-Tumor Activity by Reversing the Epigenetic Silencing of IRF6 in Urothelial Carcinoma.” Cancer Cell International 21 (April). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....88d0d2a7f73807f9be70a768161b294d&authtype=sso&custid=ns315887.